A small cassette enables conditional gene inactivation by CRISPR/Cas9

被引:0
|
作者
Paloma M. Guzzardo
Christina Rashkova
Rodrigo L. dos Santos
Raha Tehrani
Philippe Collin
Tilmann Bürckstümmer
机构
[1] Horizon Genomics GmbH,
[2] Horizon Discovery Ltd,undefined
来源
Scientific Reports | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The availability of CRISPR/Cas9 technology has enabled the rapid establishment of gene knockouts in many cell types and even whole organisms. However, conditional inactivation of essential genes remains a challenge. We devised an approach named DECAI (DEgradation based on Cre-regulated- Artificial Intron). It utilizes a small cassette of just 201 nucleotides that is inserted into the coding exon of a target gene using CRISPR/Cas9 technology and homology-directed repair. As its sequence is derived from an artificial intron, the cassette is removed by the splicing machinery and thus leaves no trace in the “off-state”. Upon activation with Cre recombinase (“on-state”), the intron is crippled and the target gene is disrupted by a series of stop codons. We exemplify the utility of this approach on several non-essential and essential human genes. Clones bearing the conditional knockout cassette are recovered at frequencies above 5% and cassette function can be traced at the genomic DNA and the mRNA level. Importantly, cassette activation leads to loss of gene expression as judged by flow cytometry, Western blot or immunofluorescence. Altogether, this highlights the broad utility of the approach for conditional gene inactivation and suggests that this tool could be used to study the loss-of-function phenotypes of essential genes.
引用
收藏
相关论文
共 50 条
  • [1] A small cassette enables conditional gene inactivation by CRISPR/Cas9
    Guzzardo, Paloma M.
    Rashkova, Christina
    dos Santos, Rodrigo L.
    Tehrani, Raha
    Collin, Philippe
    Buerckstuemmer, Tilmann
    SCIENTIFIC REPORTS, 2017, 7
  • [2] Conditional Control of CRISPR/Cas9 Function
    Zhou, Wenyuan
    Deiters, Alexander
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (18) : 5394 - 5399
  • [3] CRISPR/CAS9 GENE EDITING
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, : 26 - 27
  • [4] CRISPR/Cas9 and gene therapy
    Giono, Luciana E.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 405 - 409
  • [5] Gene inactivation using the CRISPR/Cas9 system in the nematode Pristionchus pacificus
    Hanh Witte
    Eduardo Moreno
    Christian Rödelsperger
    Jungeun Kim
    Jin-Soo Kim
    Adrian Streit
    Ralf J. Sommer
    Development Genes and Evolution, 2015, 225 : 55 - 62
  • [6] Gene inactivation using the CRISPR/Cas9 system in the nematode Pristionchus pacificus
    Witte, Hanh
    Moreno, Eduardo
    Roedelsperger, Christian
    Kim, Jungeun
    Kim, Jin-Soo
    Streit, Adrian
    Sommer, Ralf J.
    DEVELOPMENT GENES AND EVOLUTION, 2015, 225 (01) : 55 - 62
  • [7] Inactivation of Cancer Mutations Utilizing CRISPR/Cas9
    Gebler, Christina
    Lohoff, Tim
    Paszkowski-Rogacz, Maciej
    Mircetic, Jovan
    Chakraborty, Debojyoti
    Camgoz, Aylin
    Hamann, Martin V.
    Theis, Mirko
    Thiede, Christian
    Buchholz, Frank
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
  • [9] Generating rats with conditional alleles using CRISPR/Cas9
    Yuanwu Ma
    Xu Zhang
    Bin Shen
    Yingdong Lu
    Wei Chen
    Jing Ma
    Lin Bai
    Xingxu Huang
    Lianfeng Zhang
    Cell Research, 2014, 24 : 122 - 125
  • [10] Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells
    Voets, Olaf
    Tielen, Frans
    Elstak, Edo
    Benschop, Julian
    Grimbergen, Max
    Stallen, Jan
    Janssen, Richard
    van Marle, Andre
    Essrich, Christian
    PLOS ONE, 2017, 12 (08):